Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis

Published:2019-03 Issue:3 Volume:45 Page:301-309
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Wang Yizi,Ren Fang,Chen Peng,Liu Shuang,Song Zixuan,Ma Xiaoxin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference40 articles.

1. Cancer statistics;Siegel;CA A Cancer J Clin,2017

2. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006

3. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study;Ceresoli;J Gynecol Oncol,2018

4. Peritoneal-plasma barrier;Jacquet PSugarbaker;Cancer Treat Res,1996

5. Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis;Sugarbaker;Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado;Revista Colombiana de Obstetricia y Ginecología;2024-06-14

2. Discrepancy between recommendations regarding hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management: a narrative review;Chinese Clinical Oncology;2024-06

3. Should We Abandon Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer? A Meta-Analysis;Journal of Personalized Medicine;2023-11-23

4. Cytoreduction Plus Hyperthermic Intraperitoneal Chemotherapy in Primary and Recurrent Ovarian Cancer: A Single-Center Cohort Study;Surgeries;2023-11-22

5. Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents;ACS Applied Bio Materials;2023-11-02